Department of Neurology, College of Medicine, Second Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China.
Mol Genet Genomic Med. 2020 Oct;8(10):e1449. doi: 10.1002/mgg3.1449. Epub 2020 Aug 14.
To date, several studies have suggested that genes involved in monogenic forms of Parkinson's disease (PD) contribute to unrelated sporadic cases, but there is limited evidence in the Chinese population.
We performed a systematic analysis of 12 autosomal-dominant PD (AD-PD) genes (SNCA, LRRK2, GIGYF2, VPS35, EIF4G1, DNAJC13, CHCHD2, HTRA2, NR4A2, RIC3, TMEM230, and UCHL1) using panel sequencing and database filtration in a case-control study of a cohort of 391 Chinese sporadic PD patients and unrelated controls. We evaluated the association between candidate variants and sporadic PD using gene-based analysis.
Overall, 18 rare variants were discovered in 18.8% (36/191) of the index patients. In addition to previously reported pathogenic mutations (LRRK2 p.Arg1441His and p.Ala419Val), another four unknown variants were found in LRRK2, which also contribute to PD risk (p = 0.002; odds ratio (OR) = 7.83, 95% confidence intervals (CI) = 1.76-34.93). The cumulative frequency of undetermined rare variants was significantly higher in PD patients (14.1%) than in controls (3.5%) (p = 0.0002; OR=4.54, 95% CI = 1.93-10.69).
Our results confirm the strong impact of LRRK2 on the risk of sporadic PD, and also provide considerable evidence of the existence of additional undetermined rare variants in AD-PD genes that contribute to the genetic etiology of sporadic PD in a Chinese cohort.
迄今为止,已有多项研究表明,参与单基因形式帕金森病(PD)的基因也与非相关散发性病例有关,但在中国人群中证据有限。
我们对 391 名中国散发性 PD 患者和无关对照的队列进行了病例对照研究,采用panel 测序和数据库筛选,对 12 个常染色体显性 PD(AD-PD)基因(SNCA、LRRK2、GIGYF2、VPS35、EIF4G1、DNAJC13、CHCHD2、HTRA2、NR4A2、RIC3、TMEM230 和 UCHL1)进行了系统分析。我们使用基于基因的分析来评估候选变异与散发性 PD 之间的关联。
总体而言,在 191 名索引患者中发现了 18 个罕见变异,占 18.8%。除了先前报道的致病性突变(LRRK2 p.Arg1441His 和 p.Ala419Val)外,还在 LRRK2 中发现了另外四个未知变异,这些变异也会增加 PD 风险(p=0.002;优势比(OR)=7.83,95%置信区间(CI)=1.76-34.93)。未确定的罕见变异在 PD 患者中的累积频率(14.1%)明显高于对照组(3.5%)(p=0.0002;OR=4.54,95%CI=1.93-10.69)。
我们的研究结果证实了 LRRK2 对散发性 PD 风险的强烈影响,并且还为 AD-PD 基因中存在额外的未确定的罕见变异提供了有力证据,这些变异在中国人群中导致了散发性 PD 的遗传病因。